Literature DB >> 9277008

An age- and sex-structured HIV epidemiological model: features and applications.

D Low-Beer1, R L Stoneburner.   

Abstract

An important challenge in modelling the human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) epidemic is to use the increasing quantity of disease surveillance data to validate estimates and forecasts. Presented is a novel model for forecasting HIV incidence by age and sex and among sentinel groups for which data are available. This approach permits a closer relationship between forecasting and surveillance activities, and more accurate estimates validated to data. As inputs the model uses an estimate of the HIV prevalence, country demographic data, and a profile of the sexual risk of HIV infection by age, to project HIV incidence, prevalence, number of AIDS cases and population. The following examples of the use of the model are given: forecasting HIV incidence in East Africa, by age, sex, and among pregnant women; 3-5-year forecasts of HIV incidence; modelling mixed risk behaviour HIV epidemics in South-east Asia; demographic indicators; and targeting a preventive vaccine by age group.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Age Factors; Data Analysis; Demographic Factors; Diseases; Epidemiologic Methods; Estimation Technics; Evaluation; Hiv Infections; Incidence; Mathematical Model; Measurement; Methodological Studies; Models, Theoretical; Monitoring; Population; Population Characteristics; Population Forecast; Prevalence; Research Methodology; Sex Factors; Viral Diseases

Mesh:

Year:  1997        PMID: 9277008      PMCID: PMC2486943     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  13 in total

1.  The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS.

Authors:  R M Anderson; R M May; M C Boily; G P Garnett; J T Rowley
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

2.  Human immunodeficiency virus infection dynamics in east Africa deduced from surveillance data.

Authors:  R L Stoneburner; D Low-Beer; G S Tembo; T E Mertens; G Asiimwe-Okiror
Journal:  Am J Epidemiol       Date:  1996-10-01       Impact factor: 4.897

3.  Reducing the spread of HIV infection in sub-Saharan Africa: some demographic and economic implications.

Authors:  J T Rowley; R M Anderson; T W Ng
Journal:  AIDS       Date:  1990-01       Impact factor: 4.177

4.  Targeted HIV-prevention programs.

Authors:  D C Des Jarlais; N S Padian; W Winkelstein
Journal:  N Engl J Med       Date:  1994-11-24       Impact factor: 91.245

5.  Effect of sexual behavior change on long-term human immunodeficiency virus prevalence among homosexual men.

Authors:  M Morris; L Dean
Journal:  Am J Epidemiol       Date:  1994-08-01       Impact factor: 4.897

6.  Estimation and projection of adult AIDS cases: a simple epidemiological model.

Authors:  J Chin; S K Lwanga
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

7.  The treatment-free incubation period of AIDS in a cohort of homosexual men.

Authors:  J C Hendriks; G F Medley; G J van Griensven; R A Coutinho; S H Heisterkamp; H A van Druten
Journal:  AIDS       Date:  1993-02       Impact factor: 4.177

8.  High HIV-1 incidence in young women masked by stable overall seroprevalence among childbearing women in Kinshasa, Zaïre: estimating incidence from serial seroprevalence data.

Authors:  V Batter; B Matela; M Nsuami; T Manzila; M Kamenga; F Behets; R W Ryder; W L Heyward; J M Karon; M E St Louis
Journal:  AIDS       Date:  1994-06       Impact factor: 4.177

9.  The projected incidence of AIDS and estimated prevalence of HIV infection in the United States.

Authors:  J M Karon; T J Dondero; J W Curran
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988

10.  Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States.

Authors:  R Brookmeyer; M H Gail
Journal:  Lancet       Date:  1986-12-06       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.